Skip to content
MarketScale
‹ Back to IndustriesHealthcare

AI’s Advances in Healthcare Can Save Lives and Money

In recent years, artificial intelligence (AI) technology has emerged as a sort of boogeyman in countless fields. While prominent voices promise that AI will kill jobs across the board, AI has been quietly and effectively becoming an integral part of the healthcare system. The US healthcare system is in crisis, and AI seems to have…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

In recent years, artificial intelligence (AI) technology has emerged as a sort of boogeyman in countless fields. While prominent voices promise that AI will kill jobs across the board, AI has been quietly and effectively becoming an integral part of the healthcare system. The US healthcare system is in crisis, and AI seems to have some life saving answers. Let’s explore these issues, AI’s role in healthcare, and expectations for the years to come.

It’s no secret that the United States healthcare industry faces numerous challenges. From mounting costs, increasing drug-resistance, overtreatment, and a failure to adopt preventative practices, at nearly every turn there’s a major roadblock to care.[1] Fortunately, the Health Information Technology for Economic and Clinical Health (HITECH) Act, has created a large database of electronic health records. AI’s access to that data has allowed for the development of predictive models and even real-time diagnoses, treatment protocol, personalized medicine, and patient monitoring. But there’s more.

With costs soaring, both physicians and patients are more willing to use self-care kiosks or at-home tests for common illnesses like strep throat.[2] These advances are cyclical, as the more information AI has access to, and the better its processing power becomes, the more effective its treatment is. The bottom line, aside from saving lives, is that some report big data saving medicine and pharmaceuticals nearly $100 billion annually.[3] That’s not something many facilities can afford to ignore.

[1]

https://www.cs.cmu.edu/~neill/papers/ieee-is2013.pdf

[2]

http://usblogs.pwc.com/emerging-technology/ai-in-healthcare/

[3]

https://www.forbes.com/sites/bernardmarr/2017/10/09/the-amazing-ways-how-artificial-intelligence-and-machine-learning-is-used-in-healthcare/#56e12afd1c80

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The Cost of Waiting: Why Healthcare Can't Afford Slow Decisions with Mark Van Sumeren

The healthcare industry faces significant consequences when delayed decision-making occurs. Prompt and efficient action is crucial to prevent adverse impacts on patient care and operational efficiency. Addressing this issue requires a commitment to more agile and informed decision processes.

  • 01Delayed decision-making in healthcare can lead to negative impacts on patient care and operational efficiency.
  • 02Healthcare organizations are encouraged to adopt agile decision-making processes to improve effectiveness.
  • 03Implementing informed and prompt decision-making strategies can mitigate the risks of inefficiencies and poor patient outcomes.

Aug 17, 2026

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512